Abstract
The most recurrent BRCA1/BRCA2 mutation in Sweden is the BRCA1 mutation 3171ins5. In the western part of Sweden this mutation accounts for as much as 77% of identified mutations in these two genes. Our aim was to analyse in detail the haplotype and founder effects of the 3171ins5 and furthermore attempt to estimate the time of origin of the mutation. In the study we included eighteen apparently unrelated families with hereditary breast and/or ovarian cancer. At least one individual in each family had previously tested positive for the 3171ins5 mutation. Polymorphic microsatellite markers were used for the haplotype analyses. The markers were located within or flanking the BRCA1 gene spanning a region of 17.3 cM. We found several different haplotypes both for disease alleles and for the normal alleles. However, a conserved haplotype of 3.7 cM was observed in the 3171ins5 carriers spanning over four markers located within or very close to the BRCA1 gene. As this haplotype was not present in any of the normal controls it is highly likely that this is a mutation identical by descent, i.e. a true founder. The results from the haplotype analyses were used to estimate the age of the mutation. Estimations based on the Pexcess and linkage disequilibrium gives a first appearance of the mutation sometime around the 6th century, approximately 50 generations ago.
Similar content being viewed by others
Article PDF
References
Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 1994 266: 66–71
Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 1994 265: 2088–2090
Abeliovich D, Kaduri L, Lerer I et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 1997 60: 505–514
Tonin P, Weber B, Offit K, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families Nat Med 1996 2(11): 1179–1183
Levy-Lahad E, Catane R, Eisenberg S et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families Am J Hum Genet 1997 60(5): 1059–1067
Thorlacius S, Olafsdottir G, Tryggvadottir L et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes Nat Genet 1996 13(1): 117–119
Simard J, Tonin P, Durocher F et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families Nat Genet 1994 8(4): 392–398
Peelen T, van Vliet M, Petrij-Bosch A et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families Am J Hum Genet 1997 60(5): 1041–1049
Liede A, Cohen B, Black DM et al. Evidence of a founder BRCA1 mutation in Scotland Br J Cancer 2000 82: 705–711
Wagner TM, Moslinger R, Zielinski C, Scheiner O, Breiteneder H . New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families [letter] Lancet 1996 347: 1263
Ramus SJ, Kote-Jarai Z, Friedman LS et al. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer [letter] Am J Hum Genet 1997 60: 1242–1246
Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA . Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia [letter] Am J Hum Genet 1997 60: 1239–1242
Johannsson O, Ostermeyer EA, Hakansson S et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden Am J Hum Genet 1996 58(3): 441–450
Claes K, Machackova E, De Vos M, Poppe B, De Paepe A, Messiaen L . Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5+3A>G Dis Markers 1999 15(1-3): 69–73
Einbeigi Z et al. Eur J Cancer 2001 in press
Sarantaus L, Huusko P, Eerola H et al. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland Eur J Hum Genet 2000 8(10): 757–763
Neuhausen SL, Mazoyer S, Friedman L et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study Am J Hum Genet 1996 58(2): 271–280
Sham P . Statistics in Human Genetics London: Arnold, Hodder Headline Group 1998
Olofsson U . Modelling hereditary diseases using Galton-Watson processes Licentiate: Chalmers University of Technology, Göteborg University 2000
Risch N, de Leon D, Ozelius L et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population Nat Genet 1995 9: 152–159
Lander ES, Botstein D . Mapping complex genetic traits in humans: new methods using a complete RFLP linkage map Cold Spring Harb Symp Quant Biol 1986 51: 49–62
Pankratz S . Stochastic Models and Linkage Disequilibrium: Estimating the Recombination Coefficient. Ph. D Rice University 1998
Xiong M, Guo SW . Fine-scale genetic mapping based on linkage disequilibrium: theory and applications Am J Hum Genet 1997 60: 1513–1531
Rannala B, Slatkin M . Likelihood analysis of disequilibrium mapping, and related problems Am J Hum Genet 1998 62: 459–473
Ciotti P, Struewing JP, Mantelli M et al. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma- prone families Am J Hum Genet 2000 67: 311–319
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES . Parametric and nonparametric linkage analysis: a unified multipoint approach Am J Hum Genet 1996 58: 1347–1363
Tremblay M, Vezina H . New estimates of intergenerational time intervals for the calculation of age and origins of mutations Am J Hum Genet 2000 66: 651–658
Bjursell C, Stibler H, Wahlstrom J et al. Fine mapping of the gene for carbohydrate-deficient glycoprotein syndrome, type I (CDG1): linkage disequilibrium and founder effect in Scandinavian families Genomics 1997 39: 247–253
Enlund F, Samuelsson L, Enerback C et al. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden Eur J Hum Genet 1999 7: 783–790
Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA . BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history Jama 1998 279: 922–929
Acknowledgements
This research was funded by the King Gustav V Jubilee Clinic Cancer Research Foundation and the Assar Gabrielsson Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergman, A., Einbeigi, Z., Olofsson, U. et al. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9, 787–793 (2001). https://doi.org/10.1038/sj.ejhg.5200704
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200704
Keywords
This article is cited by
-
Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center
Cancer Causes & Control (2023)
-
Biogeographical origin and timing of the founder ichthyosis TGM1 c.1187G > A mutation in an isolated Ecuadorian population
Scientific Reports (2019)
-
Mutations in context: implications of BRCA testing in diverse populations
Familial Cancer (2018)
-
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population
Familial Cancer (2016)
-
Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
Breast Cancer Research and Treatment (2014)